MTOR and renal cell carcinoma: In renal cell carcinoma, TQ activates AMPK, suppresses mTOR, and increases LC3 and Beclin-1 expression, leading to autophagy, which suppresses cell migration and invasion; importantly, inhibition of autophagy reverses these anti-metastatic effects [37].